Data as of Q4 2025 (Dec 31, 2025)

GordonMD Global Investments LP

โ€ขCIK: 2039349โ€ขFiling: Q4 2025

**GordonMD Global Investments LP** manages $139M across a concentrated portfolio of 13 positions. The fund exhibits significant conviction in the healthcare sector, with its largest holding in KYTX at $41.3M. Further notable allocations include TEVA ($24.0M) and BLCO ($10.5M), indicating a focused, deep-value approach within specialized biopharma names. This structure suggests a targeted, high-conviction strategy within the life sciences landscape.

Total AUM
$139.5M
QoQ Performance
N/A
Positions
13
Top 10 Concentration
89.7%
Latest Filing
Q4 2025

Top Holdings Allocation

KYTX
TEVA
BLCO
CRNX
AMGN
RARE
TSHA
KYTX29.6%
TEVA17.2%
BLCO7.5%
CRNX7.5%
AMGN5.4%
RARE5.4%
TSHA5.2%
VIR4.0%

๐Ÿ“ˆ Biggest Buys

KYTX
KYVERNA THERAPEUTICS INC
NEW
29.6% of portfolio
TEVA
TEVA PHARMACEUTICAL INDS LTD
NEW
17.2% of portfolio
BLCO
BAUSCH PLUS LOMB CORP
NEW
7.5% of portfolio
CRNX
CRINETICS PHARMACEUTICALS IN
NEW
7.5% of portfolio
AMGN
AMGEN INC
NEW
5.4% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other94.6%
Healthcare5.4%